Wells T G, Ulstrom R A, Nevins T E
Department of Pediatrics, University of Minnesota Medical School, Minneapolis.
J Pediatr. 1988 Dec;113(6):1002-7. doi: 10.1016/s0022-3476(88)80571-7.
Symptomatic hypoglycemia developed 5 to 45 months after transplantation in nine children who had renal transplants before 6 years of age. During hypoglycemia, serum glucose levels ranged from 14 to 39 mg/dl (0.8 to 2.1 mmol/L). Hypoglycemic episodes occurred between 1.7 and 7.5 years of age. Six patients had generalized seizures; the remaining three had diaphoresis with stupor or lethargy. None of the children had serious infections, diabetes, congenital defects of glucose metabolism, or a history of treatment with insulin or oral hypoglycemic agents. Six patients had hypoglycemic symptoms after a prolonged fast, and at least four had ketosis. Eight of the nine patients were receiving propranolol when hypoglycemia occurred. No differences in the daily prednisone dose, the number of transplant rejection episodes, or the frequency of treatment with medications other than propranolol were noted between hypoglycemic patients and 56 normoglycemic age-matched renal transplant recipients. All hypoglycemic patients were subsequently treated with frequent feedings and discontinuation of propranolol. No further hypoglycemic episodes have occurred in eight of nine patients. Symptomatic hypoglycemia should be recognized as a potentially devastating complication of pediatric renal transplantation.
9名6岁前接受肾移植的儿童在移植后5至45个月出现了症状性低血糖。低血糖期间,血清葡萄糖水平在14至39mg/dl(0.8至2.1mmol/L)之间。低血糖发作发生在1.7至7.5岁之间。6名患者出现全身性癫痫发作;其余3名患者出现多汗伴昏迷或嗜睡。这些儿童均无严重感染、糖尿病、先天性葡萄糖代谢缺陷或胰岛素或口服降糖药治疗史。6名患者在长时间禁食后出现低血糖症状,至少4名患者出现酮症。9名患者中有8名在发生低血糖时正在服用普萘洛尔。低血糖患者与56名年龄匹配的血糖正常的肾移植受者相比,在每日泼尼松剂量、移植排斥发作次数或除普萘洛尔外的其他药物治疗频率方面没有差异。所有低血糖患者随后均接受了频繁喂食并停用了普萘洛尔。9名患者中有8名未再发生低血糖发作。症状性低血糖应被视为小儿肾移植潜在的毁灭性并发症。